Dr. John Bartlett

Biography

John M.S. Bartlett is an Adjunct Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. He switched to translational cancer research in 1990, building an international reputation as a translational research scientist during his time at Glasgow and Edinburgh Universities from 1993 to 2011. He has led significant research initiatives, including the establishment of the UK NEQAS scheme for HER2 ISH testing and is responsible for numerous key publications in the field. Professor Bartlett has published over 350 research articles, focusing on personalized diagnostics that address significant barriers to personalized medicine. His research group emphasizes building novel approaches for breast and prostate cancer care, collaborating with partners across Ontario and globally to integrate omics in cancer diagnosis. Furthermore, he works with guideline panels to create innovative assays that bridge the gap between omics discoveries and clinical applications, ultimately enhancing personalized treatment options for cancer patients. His work is supported by various global partnerships, including those involved in clinical trials for breast cancer.

Research Interests

Experience